PFE (Pfizer) How high will it go? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go?

PFE 25.61

+1.8%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: esterina who wrote (1524)	4/23/1998 3:01:00 PM
From: Early Out	Read Replies (2) of 9523

--said believes Pfizer Inc's anti-impotence drug Viagra has safety and efficacy issues which will limit the patient base the product can treat. Nice baseless accusation. --said Vivus will be well positioned to take advantage of erectile dysfunction patients who Viagra may not be able to treat successfully. In principle I agree with this philosophy. There are many cases of other companies or products following along on the coattails of another. However, we are talking a penile suppository here folks. No thanks. I think that most men will say, "I gave it my best shot with that pill, but there aint no way in hell I'm letting one of those MUSE things anywhere near me!" --estimated that Viagra may only be effective in 50 percent of erectile dysfunction patients and that those you find it ineffective may turn to Vivus' MUSE treatment for impotence. Don't know where they got the 50% figure, that's in direct conflict with the clinical studies. Rather than MUSE, I think it far more likely these men will wait to see if the other pill, Vasomax, is approved, and wait until next year to try that. I assume Cruttenden Roth is an MM for Vivus. Nice try boys. -jsc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next